Drug Database
Back to search

Czechia· CZ-0230352

NEODOLPASSE

A orphenadrin, kombinationen product containing diclofenac sodium + orphenadrine citrate, registered in Czechia by Fresenius Kabi s.r.o., Praha. The same ATC class is registered in 4 of our 19 countries.

ATC M03BC51

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedNEODOLPASSEATCM03BC51REGISTER NO.CZ-0230352PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about diclofenac sodium + orphenadrine citrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Orphenadrin, kombinationen is registered in 4 of 19 countries.

Countries holding a registration under ATC M03BC51 (orphenadrin, kombinationen), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 4 of them publish a price we can compare per daily dose
Search orphenadrin, kombinationen products by name

Orphenadrin, kombinationen · ATC M03BC51

4 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Italyprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
DICLOFENAC SODIUM + ORPHENADRINE CITRATE
Manufacturer
Fresenius Kabi s.r.o., Praha
Country
Czechia (CZ)
ATC code
M03BC51
ATC class
Orphenadrin, Kombinationen
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M03BC51

Orphenadrin, kombinationen, as other registers publish it.

All orphenadrin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Neodolpasse
  • Bulgaria · Neodolpasse
  • Hungary · Neodolpasse
  • Romania · Neodolpasse
  • Slovenia · Neodolpasse
  • Slovakia · Neodolpasse

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b9383526-a8e6-4ab8-81fe-ad70cfa94538
GET /v1/drugs/b9383526-a8e6-4ab8-81fe-ad70cfa94538?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INF SOL",
  "source": "sukl",
  "strength": "75MG/30MG",
  "pack_size": "1X250ML",
  "substance": "DICLOFENAC SODIUM + ORPHENADRINE CITRATE",
  "cz_kod_sukl": "0230352",
  "product_type": "CH",
  "substance_codes": "1962,1027",
  "registration_state": "R",
  "registration_number": "29/423/99-C"
}
API referenceMCP serverPlans

See everything about orphenadrin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console